Bio-Rad Laboratories, Inc. Free Cash Flow 2008–2025
Bio-Rad Laboratories, Inc. reported $374.60M of free cash flow for fiscal 2025. That was 29.4% higher than fiscal 2024. Compared with fiscal 2020, the change was -21.4%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $374.60M | +29.4% |
| FY 2024 | $289.60M | +32.7% |
| FY 2023 | $218.20M | +167.4% |
| FY 2022 | $81.60M | -84.8% |
| FY 2021 | $535.72M | +12.4% |
| FY 2020 | $476.41M | +32.6% |
| FY 2019 | $359.37M | +130.9% |
| FY 2018 | $155.67M | +2263.6% |
| FY 2017 | $-7.20M | -109.6% |
| FY 2016 | $74.63M | +0.6% |
| FY 2015 | $74.21M | -51.3% |
| FY 2014 | $152.31M | +143.8% |
| FY 2013 | $62.48M | -49.5% |
| FY 2012 | $123.61M | -22.7% |
| FY 2011 | $159.85M | +16.3% |
| FY 2010 | $137.46M | -46.5% |
| FY 2009 | $257.03M | +141.2% |
| FY 2008 | $106.56M | — |
Source: Bio-Rad Laboratories, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BIO 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Bio-Rad Laboratories, Inc. reported $374.60M of free cash flow for fiscal 2025. That was 29.4% higher than fiscal 2024. Compared with fiscal 2020, the change was -21.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Bio-Rad Laboratories, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBio-Rad Laboratories, Inc. — frequently asked questions
What is Bio-Rad Laboratories, Inc.'s free cash flow?
Bio-Rad Laboratories, Inc. (BIO) reported free cash flow of $374.60M for fiscal year 2025, per its SEC filings.
How has Bio-Rad Laboratories, Inc.'s free cash flow changed over time?
Between fiscal 2008 and 2025, BIO's free cash flow grew at roughly 7.7% per year (compound annual rate), from $106.56M to $374.60M.
Where does this data come from?
Figures are computed from Bio-Rad Laboratories, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.